BGM
BGM Group Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$0.26
−0.12%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$0.26
From 52W high−97.80%
Volume23767.00
Market cap$103.64M
P/E (TTM)—
P/S (TTM)2.7x
Div yield—
Key dataSep 18, 2026
Open
$0.26
From 52W high
−97.80%
Volume
23767.00
Market cap
$103.64M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−8.5x
P/E (TTM)
—
RSI (14)
43.9
MomentumView details →
1D Return
−0.12%
YTD Return
−92.98%
SummaryUpdated Mar 1, 2026
BGM Group Ltd. (NASDAQ:BGM) is a Chinese pharmaceutical and agricultural company that manufactures and distributes active pharmaceutical ingredients, traditional Chinese medicine derivatives, and organic fertilizers. Originally incorporated in 2019 as Qilian International Holding Group Limited, the company rebranded to BGM Group Ltd. in October 2024. Headquartered in Chengdu, China, BGM operates as a specialty manufacturer serving both the pharmaceutical and agricultural sectors, with its products ranging from licorice-based medicines to heparin preparations and organic fertilizers.
Similar companies
Latest newsMore news →
No recent news for BGM.